HART gets delisting warning from Nasdaq over share price

• Nasdaq has sent Harvard Apparatus Regenerative Technology (HART -1.6%) a delisting warning after the company's share price missed the $1 closing bid requirement for 30 business days.
• HART will have until May 2 to regain compliance, by raising the closing bid over $1 for at least 10 straight business days.
• CEO Jim McGorry says that after spending the early part of his tenure on strategy, he can now focus on investor outreach and putting the company back in compliance.